The Olaparib Drugs Market focuses on olaparib, a PARP inhibitor used in selected cancer indications. It works by interfering with DNA repair processes and can be particularly relevant in tumors with certain DNA-repair deficiencies, including some BRCA-associated cancers.
Current Market Landscape
Olaparib is used in specific settings for ovarian, breast, pancreatic, and prostate cancers,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek